Results 21 to 30 of about 120,543 (256)

Stimulant use disorder diagnosis and opioid agonist treatment dispensation following release from prison: a cohort study

open access: yesSubstance Abuse Treatment, Prevention, and Policy, 2022
Background Concurrent opioid and stimulant use is on the rise in North America. This increasing trend of use has been observed in the general population, and among people released from prison in British Columbia (BC), who face an elevated risk of ...
Heather Palis   +6 more
doaj   +1 more source

Wisdom of the CROUD:  Development and validation of a patient-level prediction model for opioid use disorder using population-level claims data.

open access: yesPLoS ONE, 2020
OBJECTIVE:Some patients who are given opioids for pain could develop opioid use disorder. If it was possible to identify patients who are at a higher risk of opioid use disorder, then clinicians could spend more time educating these patients about the ...
Jenna Marie Reps   +2 more
doaj   +1 more source

Methadone for Opioid Use Treatment during Pregnancy: Trends in Postpartum Dose Adjustments

open access: yesAmerican Journal of Perinatology Reports, 2020
Objective This study examines methadone dose adjustment postpartum. Methods A retrospective study of women with methadone for opioid use treatment (OUT) during pregnancy was performed.
Clara Ward, Carl W. Christensen
doaj   +1 more source

Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study

open access: yesAddiction Science & Clinical Practice, 2022
Background Residential treatment is a common approach for treating opioid use disorder (OUD), however, few studies have directly compared it to outpatient treatment.
Daniel M. Hartung   +11 more
doaj   +1 more source

SnapShot: Neurobiology of opioid use disorder [PDF]

open access: yesCell, 2021
The use of opioid drugs and related overdose deaths, which rose to epidemic proportions over the past decade, have been exacerbated by the COVID pandemic, a time of great uncertainty and isolation. Much is known about opioid pharmacology and related neural circuits that, combined with novel emerging neurobiological insights, can help guide new ...
Tanni Rahman   +3 more
openaire   +3 more sources

Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study

open access: yesAddiction Science & Clinical Practice, 2022
Background Medication for opioid use disorder (MOUD) reduces mortality, but few patients access MOUD. At a Federally Qualified Health Center (FQHC), we implemented a low barrier model of MOUD, including same-day MOUD initiation and a harm reduction ...
Jamie Carter   +9 more
doaj   +1 more source

Medicaid expansion and treatment for opioid use disorders in Oregon: an interrupted time-series analysis

open access: yesAddiction Science & Clinical Practice, 2019
Background The study examined the association of the Affordable Care Act’s 2014 Medicaid expansion on the use of psychosocial services and pharmacotherapies for opioid use disorders among Oregon Medicaid recipients.
Dennis McCarty   +3 more
doaj   +1 more source

The association of criminal justice supervision setting with overdose mortality: a longitudinal cohort study. [PDF]

open access: yes, 2020
Background and aimsDespite the high prevalence of substance use among people in the US criminal justice system, little is known about the incidence of overdose mortality by use patterns, drug convictions and supervision setting.
Anderson R. N.   +8 more
core   +2 more sources

Single high-dose buprenorphine for opioid craving during withdrawal. [PDF]

open access: yes, 2018
BackgroundOpioid use disorder is one of the most prevalent addiction problems worldwide. Buprenorphine is used as a medication to treat this disorder, but in countries where buprenorphine is unavailable in combination with naloxone, diversion can be a ...
Ahmadi, Jamshid   +3 more
core   +2 more sources

Family member opioid prescriptions and opioid use disorder [PDF]

open access: yesAddictive Behaviors, 2019
It is recognized that family members are a major source of diverted opioids. Yet it is not known how family member opioid prescriptions predict the development of an opioid use disorder (OUD).We conducted an observational study using commercial health care claims to investigate the association between a family member opioid prescription and an ...
Mir M. Ali   +6 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy